Evidence map›Paper›PMID 41679957›Full record

ArticleJournal of applied clinical medical physics2026

Feasibility of proton daily QA prototype for pencil beam scanning carbon ion beam therapy.

Matthias Witt, Veronika Flatten, Andreas Schönfeld, Kilian-Simon Baumann, Uli Weber, Klemens Zink

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthias WittInstitute of Medical Physics and Radiation Protection, University of Applied Science, Gießen, Germany.ORCID https://orcid.org/0000-0002-1304-9079
Veronika FlattenSunNuclear, a Mirion Medical Company, Melbourne, Florida, USA.
Andreas SchönfeldSunNuclear, a Mirion Medical Company, Melbourne, Florida, USA.
Kilian-Simon BaumannInstitute of Medical Physics and Radiation Protection, University of Applied Science, Gießen, Germany.
Uli WeberInstitute of Medical Physics and Radiation Protection, University of Applied Science, Gießen, Germany.
Klemens ZinkInstitute of Medical Physics and Radiation Protection, University of Applied Science, Gießen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe complexity of beam delivery and the limited availability of dedicated quality assurance (QA) devices present unique challenges for carbon ion beam therapy. Most existing systems are designed for single-parameter verification and have been adapted from photon or proton workflows, resulting in time-consuming QA procedures. This study aimed to evaluate the feasibility of using a proton QA prototype device (DQA-P) in a pencil beam scanning (PBS) carbon ion facility, with the aim of enabling fast, efficient, multiparameter QA.

methodsThe DQA-P integrates 25 ionization chambers at three water-equivalent depths, enabling the simultaneous measurement of multiple beam parameters, such as dose output, range, spot size, and spot position, in accordance with the recommendations of the AAPM TG-224. Over 60 measurement sessions were performed, including 47 sessions involving intentional deviations in individual beam parameters, in order to assess sensitivity. The measurements were analyzed retrospectively using custom MATLAB scripts to evaluate accuracy, reproducibility, and the impact of setup uncertainties.

resultsThe DQA-P prototype successfully measured all QA parameters within clinically acceptable tolerances. Dose output measurements showed a standard deviation of 0.5% around the mean, with minimal systematic deviation. Spot position measurements exhibited a mean deviation of 0.16 mm, with a standard deviation of 0.32 mm. The device's sensitivity was demonstrated by its reliable detection of intentional positional offsets of

conclusionsThe DQA-P prototype demonstrated feasibility for daily QA in PBS carbon ion beam therapy, offering a short overall measurement time of approximately 5 min, efficient data acquisition, and simultaneous multiparameter verification within a single setup. This is a significant improvement on the conventional daily QA procedure, which uses two different detector types for independent dose and spot position measurements. In the standard workflow, both detectors must be positioned individually using the in-room laser system, connected to the readout electronics and irradiated using the daily beam plan. Altogether, this procedure takes around 15-20 min. Although certain limitations remain-particularly in spot size accuracy and range determination-the device showed sufficient sensitivity and stability for daily QA purposes. Its use has the potential to streamline QA procedures, reduce beam time, and enhance workflow efficiency in carbon ion therapy.

Indexed as

Heavy Ion RadiotherapyNeoplasmsPhantoms, ImagingProton TherapyQuality Assurance, Health CareRadiotherapy Planning, Computer-AssistedFeasibility StudiesHumansRadiotherapy DosageRadiotherapy, Intensity-ModulatedReproducibility of ResultsRetrospective Studiescarbon ion therapydaily QAPBS QA

Identifiers

PMID41679957
PMCPMC12900580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.